About Generis Farmaceutica
Generis Farmaceutica is a company based in Amadora (Portugal) founded in 2002 was acquired by Aurobindo Pharma in January 2017. Generis Farmaceutica offers products and services including Generic Medicines for Ambulatory Use and Generic Medicines for Hospitals.
- Headquarter Amadora, Portugal
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Generis Farmacêutica, S.A.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Aurobindo Pharma
& 1 more
-
Employee Count
Not available
-
Acquired by
Aurobindo Pharma
(Jan 07, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Generis Farmaceutica
Generis Farmaceutica offers a comprehensive portfolio of products and services, including Generic Medicines for Ambulatory Use and Generic Medicines for Hospitals.
Generic medicines are produced and supplied for outpatient treatment in the market
Generic medicines are provided as part of the largest portfolio for hospital use in Portugal
People of Generis Farmaceutica
Unlock access to complete
Funding Insights of Generis Farmaceutica
Investors in Generis Farmaceutica
Generis Farmaceutica has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Aurobindo Pharma and Magnum Industrial Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A leading private equity firm focused on Iberian markets is operated.
|
Locked | Locked | Locked | |
|
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
Locked | Locked | Locked |
Investor details for Generis Farmaceutica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Generis Farmaceutica
Investment portfolio details for Generis Farmaceutica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Generis Farmaceutica
Detailed financials for Generis Farmaceutica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Generis Farmaceutica Comparisons
Peer comparison for Generis Farmaceutica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Generis Farmaceutica
Detailed competitors of Generis Farmaceutica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Generis Farmaceutica
Complete news archive for Generis Farmaceutica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Generis Farmaceutica
Generis Farmaceutica was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Generis Farmaceutica is headquartered in Amadora, Portugal.
Generis Farmaceutica was established in 2002 in Amadora, Portugal, within the pharmaceutical sector. Operations center on the production of generic medications, primarily targeting cardiovascular diseases, neurological disorders, and pain management. Additional categories include antihistamines, anti-infectives, and treatments for gastrointestinal, genitourinary, respiratory, dermatological, and diabetic conditions. The companys activities remain focused on these therapeutic areas to support healthcare needs.
Generis Farmaceutica offers Generic Medicines for Ambulatory Use and Generic Medicines for Hospitals.
Generis Farmaceutica has 2 investors. Key investors include Aurobindo Pharma, and Magnum Industrial Partners.